There are currently no drugs approved in the European Union to treat the liver condition known as MASH, but a new trial of ...

A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by the common condition ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...

As broader approval for GLP-1 weight loss drugs spurs higher demand, it’s also causing employer drug spending to spike.

Growth stocks often don't come cheap, especially when their prospects look great, as is the case with Eli Lilly ( LLY 1.09%).

Currently, doctors sometimes use a drug called spironolactone to treat this condition. It’s a medication that’s been around ...

Mukhopadhyay took Mounjaro, an antidiabetic medication also used for weight loss, and saw dramatic results—losing 15 percent of her body weight over 18 months. She was feeling physically better, ...

There is a low incidence rate of suicide-related adverse events among adults with diabetes or obesity being treated with GLP-1 RAs.

Semaglutide, the active ingredient in popular drugs Ozempic and Wegovy, isn’t without its risks. A recent study has found ...

This inexpensive generic significantly reduced knee pain in a small trial of people who are overweight or have obesity.

Advancing diabetes therapy requires an integrative approach that uses emerging technologies. This research topic focuses on the synergy between ...

Carnegie Mellon researchers have used FRESH 3D bioprinting to create the first collagen-based microphysiologic systems, ...